Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

Author(s):Paton, N.I. | Kityo, C. | Thompson, J. | Nankya, I. | Bagenda, L. | Hoppe, A. | Hakim, J. | Kambugu, A. | van Oosterhout, J.J. | Kiconco, M. | Bertagnolio, S. | Easterbrook, P.J. | Mugyenyi, P. | Walker, A.S. | Agweng, E. | Awio, P. | Bakeinyaga, G. | Isabirye, C. | Kabuga, U. | Kasuswa, S. | Katuramu, M. | Kityo, C. | Kiweewa, F. | Kyomugisha, H. | Lutalo, E. …read more

Source:: cowley, sally a.” 7102482900 “james, william s.” 35479049300 “moore, michael d.